Tenaya Therapeutics Statistics Share Statistics Tenaya Therapeutics has 162.98M
shares outstanding. The number of shares has increased by 105.72%
in one year.
Shares Outstanding 162.98M Shares Change (YoY) 105.72% Shares Change (QoQ) 0.19% Owned by Institutions (%) 19.39% Shares Floating 152.5M Failed to Deliver (FTD) Shares 8,540 FTD / Avg. Volume 0.24%
Short Selling Information The latest short interest is 15.05M, so 9.23% of the outstanding
shares have been sold short.
Short Interest 15.05M Short % of Shares Out 9.23% Short % of Float 25.36% Short Ratio (days to cover) 4.37
Valuation Ratios The PE ratio is -1.09 and the forward
PE ratio is -2.86.
Tenaya Therapeutics's PEG ratio is
0.05.
PE Ratio -1.09 Forward PE -2.86 PS Ratio 0 Forward PS 79.2 PB Ratio 1.31 P/FCF Ratio -1.33 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tenaya Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.22,
with a Debt / Equity ratio of 0.15.
Current Ratio 4.22 Quick Ratio 4.22 Debt / Equity 0.15 Debt / EBITDA -0.13 Debt / FCF -0.15 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.15M Employee Count 97 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -8.47% in the
last 52 weeks. The beta is 3.16, so Tenaya Therapeutics's
price volatility has been higher than the market average.
Beta 3.16 52-Week Price Change -8.47% 50-Day Moving Average 1.14 200-Day Moving Average 0.89 Relative Strength Index (RSI) 63.71 Average Volume (20 Days) 3,603,123
Income Statement
Revenue n/a Gross Profit n/a Operating Income -115.95M Net Income -111.13M EBITDA -102.66M EBIT -111.13M Earnings Per Share (EPS) -1.31
Full Income Statement Balance Sheet The company has 4.32M in cash and 13.61M in
debt, giving a net cash position of -9.29M.
Cash & Cash Equivalents 4.32M Total Debt 13.61M Net Cash -9.29M Retained Earnings -514.41M Total Assets 122.15M Working Capital 63.22M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -90.5M
and capital expenditures -1.02M, giving a free cash flow of -91.53M.
Operating Cash Flow -90.5M Capital Expenditures -1.02M Free Cash Flow -91.53M FCF Per Share -1.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
